Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.

Saved in:
Bibliographic Details
Title: Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
Authors: Eriksson, Jule A.1,2, Wanka, Christina1, Burger, Michael C.1, Urban, Hans1, Hartel, Ines1, von Renesse, Janusz3, Harter, Patrick N.3, Mittelbronn, Michel3,4, Steinbach, Joachim P.1 joachim.steinbach@med.uni-frankfurt.de, Rieger, Johannes1,5
Source: Journal of Neurochemistry. Feb2018, Vol. 144 Issue 4, p421-430. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00223042
DOI:10.1111/jnc.14264